Cancer-A silent killer: An overview
AR Yadav, SK Mohite - Asian Journal of Pharmaceutical …, 2020 - indianjournals.com
Cancer can be characterized as a disease where an uncontrollably growing group of
abnormal cells disregarding the normal mechanism of cell division. The healthy cells that …
abnormal cells disregarding the normal mechanism of cell division. The healthy cells that …
Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 …
AM Sayed, FA Taher, MRK Abdel-Samad… - Bioorganic …, 2021 - Elsevier
A new series of sulfonamide endowed with hydrazone coupled to dimethyl and/or diethyl
malonates were prepared. Various sulfa drugs were diazotized and followed by coupling …
malonates were prepared. Various sulfa drugs were diazotized and followed by coupling …
Dual human carbonic anhydrase/cyclooxygenase-2 inhibitors: a promising approach for cancer treatment
M Mahboubi-Rabbani, A Zarghi - Anti-Cancer Agents in …, 2021 - ingentaconnect.com
Human Carbonic Anhydrase (hCA) and Cyclooxygenase-2 (COX-2) have been known for a
long to be chiefly involved in both the pathogenesis and progression of cancer and cancer …
long to be chiefly involved in both the pathogenesis and progression of cancer and cancer …
Comparative study between the anti-P. falciparum activity of triazolopyrimidine, pyrazolopyrimidine and quinoline derivatives and the identification of new PfDHODH …
FF Silveira, JO de Souza, LVB Hoelz… - European Journal of …, 2021 - Elsevier
In this work, we designed and synthesized 35 new triazolopyrimidine, pyrazolopyrimidine
and quinoline derivatives as P. falciparum inhibitors (3D7 strain). Thirty compounds …
and quinoline derivatives as P. falciparum inhibitors (3D7 strain). Thirty compounds …
Evaluation of novel coumarin-proline sulfonamide hybrids as anticancer and antidiabetic agents
SD Durgapal, SS Soman - Synthetic Communications, 2019 - Taylor & Francis
Cancer and diabetes are considered as two major diseases affecting human health
worldwide. Various therapies are available for treatment of cancer and diabetes individually …
worldwide. Various therapies are available for treatment of cancer and diabetes individually …
Cytotoxicity and antiangiogenic effects of Rhus coriaria, Pistacia vera and Pistacia khinjuk oleoresin methanol extracts
M Mirian, M Behrooeian, M Ghanadian… - Research in …, 2015 - journals.lww.com
Angiogenesis, formation of new blood vessels, play an important role in some diseases such
as cancer and its metastasis. Using angiogenesis inhibitors, therefore, is one of the ways for …
as cancer and its metastasis. Using angiogenesis inhibitors, therefore, is one of the ways for …
Novel Benzo[4,5]imidazo[1,2-a]pyrimidine derivatives as selective Cyclooxygenase-2 Inhibitors: Design, synthesis, docking studies, and biological evaluation
The present study was aimed at the synthesis and evaluation of a new series of benzo [4, 5]
imidazo [1, 2-a] pyrimidine having a methylsulfonyl group as COX-2 (cyclooxygenase-2) …
imidazo [1, 2-a] pyrimidine having a methylsulfonyl group as COX-2 (cyclooxygenase-2) …
Sulfonamide hybrid schiff bases of anthranilic acid: synthesis, characterization and their biological potential
In the present work, the novel Schiff bases (03–20) of 4-chloro-N-[2-(hydrazinocarbonyl)
phenyl] benzenesulfonamide (02) were synthesized by reacting it with various aldehydes. 4 …
phenyl] benzenesulfonamide (02) were synthesized by reacting it with various aldehydes. 4 …
[HTML][HTML] Synthesis and biological investigation of some novel sulfonamide and amide derivatives containing coumarin moieties
New sulfonamide and amide derivatives containing coumarin moieties; oxo-2H-chromen-
sulfamoylphenylacetamides and oxo-2H-chromen-arylacetamides were synthesized starting …
sulfamoylphenylacetamides and oxo-2H-chromen-arylacetamides were synthesized starting …
[HTML][HTML] In-vitro comparison of cytotoxicity of two bioactive glasses in micropowder and nanopowder forms
M Rismanchian, N Khodaeian… - Iranian journal of …, 2013 - ncbi.nlm.nih.gov
The cytotoxicity of the biomaterials is a key issue that should be addressed prior to pre-
clinical applications. This study was designed to evaluate and compare the cytotoxixity of …
clinical applications. This study was designed to evaluate and compare the cytotoxixity of …